These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29058070)

  • 1. Prognostic value of plasma NT-proBNP levels in very old patients with moderate renal insufficiency in China.
    Gao P; Zhu Q; Bian S; Liu H; Xie H
    Z Gerontol Geriatr; 2018 Dec; 51(8):889-896. PubMed ID: 29058070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
    Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
    Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Plasma NT-proBNP levels in Hospitalized Patients Older than 80 Years of Age in a Hospital in Beijing, China.
    Zhu Q; Gao P; Fu S; Wang H; Bai Y; Luo L; Ye P
    Arq Bras Cardiol; 2021 Jun; 116(6):1027-1036. PubMed ID: 34133582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
    Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
    Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
    Spanaus KS; Kronenberg F; Ritz E; Schlapbach R; Fliser D; Hersberger M; Kollerits B; König P; von Eckardstein A;
    Clin Chem; 2007 Jul; 53(7):1264-72. PubMed ID: 17478561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease.
    Fu S; Luo L; Ye P; Yi S; Liu Y; Zhu B; Wang L; Xiao T; Bai Y
    Clin Interv Aging; 2013; 8():409-17. PubMed ID: 23723693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.
    Gong X; Zhang T; Feng S; Song D; Chen Y; Yao T; Han P; Liu Y; Li C; Song Z; Gao J; Cui Z; Ma J; Liu Y
    Ann Palliat Med; 2021 May; 10(5):5231-5243. PubMed ID: 34044561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP level in stage 3-4 chronic kidney disease and mortality in long-term follow-up: HAPPY study subgroup analysis.
    Şimşek MA; Değertekin M; Türer Cabbar A; Hünük B; Aktürk S; Erdoğmuş S; Mutlu B; Kozan Ö
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):454-460. PubMed ID: 32633264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.
    Tsai YC; Tsai HJ; Lee CS; Chiu YW; Kuo HT; Lee SC; Chen TH; Kuo MC
    PLoS One; 2018; 13(8):e0202733. PubMed ID: 30133531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C; Manzoor S; Wright J; Roberts SA; Wood G; McDowell G; Kalra PA
    Kidney Blood Press Res; 2009; 32(5):373-9. PubMed ID: 19887825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
    Untersteller K; Girerd N; Duarte K; Rogacev KS; Seiler-Mussler S; Fliser D; Rossignol P; Heine GH
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1978-1988. PubMed ID: 27515593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
    PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
    Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A
    Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 20. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.